Dividend-paying companies are an oasis in the desert of underperforming stocks. They offer solid payouts today and the promise of capital gains tomorrow. According to a study by Ibbotson, reinvested dividends made up about 40% of total stock returns from 1926 to 2006. In fact, dividend investing is so appealing that superinvestor Warren Buffett has made dividend stocks a significant component of his portfolio.
When searching for great dividend stocks, it makes a lot of sense to start with companies that have been playing the dividend game the longest. Standard & Poor's has culled the dividend winners from the also-rans in a list it calls the "dividend aristocrats."
Let's examine the top dividend aristocrats by yield in the Pharmaceuticals, Biotechnology, and Life Sciences industry. For context, I've also included their five-year annualized dividend growth rate.
|
Company |
Trailing Yield |
5-Year Dividend Growth Rate |
|---|---|---|
|
Abbott Laboratories |
3.7% | 9.7% |
|
Johnson & Johnson |
3.5% | 10.9% |
Source: Capital IQ, a division of Standard & Poor's.
In its annual reconstitution of the Dividend Aristocrats index recently, S&P eliminated Eli Lilly
These aren't formal recommendations -- just ideas for your own further research. Still, they could give you a great start toward finding companies capable of paying rising dividends for a quarter-century or more. S&P just announced its dividend aristocrats for 2011, and you can see the top yielders for yourself.
Interested in reading more about Johnson & Johnson? Add it to My Watchlist, and we'll automatically aggregate our Foolish analysis on the stock just for you.
These are a handful of the thousands of public companies that can help you secure a third income for life. If you'd like to see which others make the cut, try Income Investor free for the next 30 days.
